Safety and feasibility of concomitant urogynecologic and gynecologic oncology surgical procedures

This joint Clinical Consensus Statement on the safety and feasibility of concomitant urogynecologic and gynecologic oncology surgical procedures reflects statements drafted by content experts from the American Urogynecologic Society and the Society of Gynecologic Oncology. The writing group used a Delphi process to evaluate statements developed from a structured literature search and assessed consensus. A total of 35 statements were assessed in the following categories: (1) background, (2) treatment options, (3) timing of concurrent surgery, (4) risk factors, and (5) value-based care. Of the 35 statements, 28 reached consensus on initial review. Three statements were omitted, and 4 statements were revised and reached consensus following second review utilizing the Delphi process. WHY THIS MATTERS: Pelvic floor disorders are common among patients with gynecologic cancer and significantly affect quality of life. Despite this significant overlap, only a minority of patients undergo concomitant urogynecologic surgical procedures at the time of surgical intervention for a gynecologic malignancy, and there is no current consensus on patient selection, timing of concurrent procedures, and best practices in the gynecologic oncology population. A critical evaluation of the current evidence surrounding the safety and feasibility of joint procedures is crucial to inform joint decision making with patients and identify knowledge gaps for future research.